EXACT Total Current Liabilities from 2010 to 2024
| EXAS Stock | USD 52.91 0.16 0.30% |
Total Current Liabilities | First Reported 2000-06-30 | Previous Quarter 668.6 M | Current Value 723.7 M | Quarterly Volatility 211.7 M |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Total Current Liabilities |
Latest EXACT Sciences' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of EXACT Sciences over the last few years. Total Current Liabilities is an item on EXACT Sciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of EXACT Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. EXACT Sciences' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
EXACT Total Current Liabilities Regression Statistics
| Arithmetic Mean | 206,964,529 | |
| Geometric Mean | 57,725,448 | |
| Coefficient Of Variation | 112.96 | |
| Mean Deviation | 207,400,383 | |
| Median | 68,124,000 | |
| Standard Deviation | 233,793,941 | |
| Sample Variance | 54659.6T | |
| Range | 575.5M | |
| R-Value | 0.89 | |
| Mean Square Error | 11969.3T | |
| R-Squared | 0.80 | |
| Slope | 46,661,150 | |
| Total Sum of Squares | 765234.5T |
EXACT Total Current Liabilities History
About EXACT Sciences Financial Statements
EXACT Sciences shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 514.7 M | 540.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.